Am J Public Health
- ABRESCH CJ, Stafford IA, Johnson RM, Olabanji K, et al
Congenital Syphilis: From Near-Elimination to Crisis.
Am J Public Health. 2026;116:103-112.
Antimicrob Agents Chemother
- YOUSSEF EG, Gebremariam T, Gu Y, Patterson H, et al
Efficacy assessments of EL219, a next-generation polyene antifungal, in
immunosuppressed mice infected with drug-sensitive and drug-resistant Aspergillus
isolates.
Antimicrob Agents Chemother. 2025 Dec 5:e0140025. doi: 10.1128/aac.01400.
- ABDELSATTAR AS, Kikiowo B, Abutaleb NS, Dove AS, et al
Repurposing epetraborole to combat Neisseria gonorrhoeae and Chlamydia
trachomatis infections.
Antimicrob Agents Chemother. 2025 Dec 5:e0144525. doi: 10.1128/aac.01445.
- LAVOIE T, Sierra T, Daffinee K, Pogue JM, et al
Unlocking potentials: the impact of meropenem, meropenem-vaborbactam, and
ceftazidime-avibactam in combating carbapenem-resistant Enterobacter cloacae.
Antimicrob Agents Chemother. 2025 Nov 19:e0090625. doi: 10.1128/aac.00906.
- APPLEBACH E, Amburgey-Crovetti K, Bakotic WL, Adhikari TB, et al
Prevalence and diversity of antifungal resistance in Fusarium isolates across
clinical and agricultural settings in the United States.
Antimicrob Agents Chemother. 2025;69:e0120825.
- BLEICK CR, Van Helden SR, Berti AD, Richa R, et al
Optimizing phage-antibiotic combinations: impact of administration order against
daptomycin non-susceptible (DNS) MRSA clinical isolates.
Antimicrob Agents Chemother. 2025;69:e0069925.
- JUAN C-H, Chou S-H, Chuang C, Lin S-N, et al
Carbapenems versus non-carbapenems as definitive treatment for hypervirulent
Klebsiella pneumoniae bacteremia in Taiwan.
Antimicrob Agents Chemother. 2025;69:e0084625.
- HAHN MM, Anderson MS, Snyder M, Du W, et al
Pharmacokinetic modeling and efficacy of ceftobiprole medocaril against pneumonic
tularemia in cynomolgus macaques.
Antimicrob Agents Chemother. 2025;69:e0127825.
- EDWARDS B, Ripperton R, Tilley A, Chastain DB, et al
Insights into current coccidioidomycosis therapeutic pathways.
Antimicrob Agents Chemother. 2025;69:e0146525.
- NODARI CS, Bai Q, Cayo R, Streling AP, et al
ISAba1-mediated bla(ADC) disruption restores third-generation cephalosporin
susceptibility in a clinical Acinetobacter baumannii isolate.
Antimicrob Agents Chemother. 2025;69:e0070725.
- CADENAS-JIMENEZ I, Gonzalez-Diaz A, Berbel D, Costa-Primo R, et al
First report of a DIM-1-producing Pseudomonas aeruginosa in Spain: genomic
characterization and resistance determinants.
Antimicrob Agents Chemother. 2025;69:e0131125.
- HESELPOTH RD, Euler CW, Fischetti VA
Second-generation lysocins as therapeutics for treating Pseudomonas aeruginosa
infections.
Antimicrob Agents Chemother. 2025;69:e0131225.
- RODRIGUEZ-OCHOA JL, Sauco-Carballo C, Perez-Palacios P, Merino-Bohorquez V, et al
Pharmacokinetic/pharmacodynamic optimization of temocillin treatment against
CTX-M-15-producing Klebsiella pneumoniae isolates in a hollow-fiber infection
model.
Antimicrob Agents Chemother. 2025;69:e0094625.
- ALVARADO-OROSCO N, Gomis-Font MA, Sastre-Femenia MA, Ribera Ortiz S, et al
First nationwide survey on Pseudomonas aeruginosa in Bolivia: susceptibility
profiles, resistome, and genomic epidemiology.
Antimicrob Agents Chemother. 2025;69:e0116325.
- WANGCHINDA W, Wu JY, Abbo LM, Ackley R, et al
Effectiveness of imipenem-relebactam for multidrug-resistant Pseudomonas
aeruginosa in pneumonia and bloodstream infections in the United States (MIRAGE).
Antimicrob Agents Chemother. 2025;69:e0132525.
- HE G, Zeng S, Banki LT, Zhou W, et al
Clinical emergence of inducible macrolide resistance mediated by acquired erm(41)
C28T mutation in Mycobacterium abscessus.
Antimicrob Agents Chemother. 2025 Nov 6:e0115325. doi: 10.1128/aac.01153.
- FU Y, Zhang Y, Zhao J, Xie J, et al
Emergence of co-resistance to imipenem/relebactam and ceftazidime/avibactam in
clinical Klebsiella pneumoniae ST11 clone due to KPC-2 N132S and CTX-M-65
S130G/P167S substitutions.
Antimicrob Agents Chemother. 2025;69:e0089125.
- SLAIN N, Lucas K, Kunz Coyne AJ
Comparison between cefepime and carbapenem therapy for deep-seated AmpC-producing
Enterobacterales infections: a propensity-weighted retrospective cohort study.
Antimicrob Agents Chemother. 2025;69:e0092825.
- HODBERT E, Lemenand O, Thibaut S, Coeffic T, et al
Exploring multidrug resistance patterns in community-acquired Escherichia coli
urinary tract infections with machine learning.
Antimicrob Agents Chemother. 2025 Oct 31:e0042225. doi: 10.1128/aac.00422.
- VANACHAYANGKUL P, Ruamsap N, Caridha D, Imerbsin R, et al
Preclinical in vitro and in vivo evaluation of omadacycline against
multidrug-resistant Acinetobacter baumannii.
Antimicrob Agents Chemother. 2025;69:e0093225.
- PAI MP, Cojutti PG, Gatti M, Rinaldi M, et al
Keeping the horse with the cart: are we underdosing tazobactam even when using
continuous-infusion ceftolozane/tazobactam for effectively preventing resistance
development by ESBL-producing Enterobacterales?
Antimicrob Agents Chemother. 2025;69:e0121525.
- GONZALEZ-PINTO L, Gomis-Font MA, Perez-Rodriguez G, Blanco-Martin T, et al
Contribution of mutational resistance mechanisms and acquired beta-lactamases to
cefiderocol/xeruborbactam susceptibility in Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 2025;69:e0104825.
- UPTON CM, Calderin JM, Diacon AH, Boeree MJ, et al
Cerebrospinal fluid penetration of cycloserine/terizidone and clofazimine in
patients with pulmonary TB.
Antimicrob Agents Chemother. 2025;69:e0093125.
- TAKEI K, Kanamori H, Sakata R, Ogawa M, et al
High-risk clonal expansion of IMP-producing Enterobacter cloacae complex in
regional Japanese healthcare settings.
Antimicrob Agents Chemother. 2025;69:e0095325.
- CUI Y, Feng X, Wang J, Liu L, et al
Construction and assessment of a predictive framework for Enterobacterales
bloodstream infection in real-world adult onco-hematology patients using
Lasso-Cox regression.
Antimicrob Agents Chemother. 2025;69:e0097325.
- BENAVENT E, Lora-Tamayo J, Ulldemolins M, Pons-Oltra P, et al
Efficacy, safety, and population pharmacokinetics of a single 1500mg dose of
dalbavancin for short-term therapy in patients with chronic prosthetic joint
infections.
Antimicrob Agents Chemother. 2025;69:e0077325.
- SHAW S, Pragasam AK, Chowdhury G, Samanta P, et al
Genomic portrayal of emerging carbapenem-resistant El Tor variant Vibrio cholerae
O1.
Antimicrob Agents Chemother. 2025 Oct 17:e0074025. doi: 10.1128/aac.00740.
Chest
- TIEW PY, Narayana JK, Jaggi TK, Koh MS, et al
Aspergillus fumigatus sensitization is associated with high-risk bronchiectasis.
Chest. 2025 Dec 10:S0012-3692(25)05826-X. doi: 10.1016/j.chest.2025.
Clin Infect Dis
- MCCREESH N, MacPherson P, Bampi JVB, Engel N, et al
Reported Tuberculosis Symptoms: An Inadequate Classifier of Disease State.
Clin Infect Dis. 2025 Dec 10:ciaf611. doi: 10.1093.
- DALE KD
Why we should move away - not towards - symptom-based terminology and policy in
tuberculosis.
Clin Infect Dis. 2025 Dec 5:ciaf667. doi: 10.1093.
- LINDER JA, Watson ME, Wessels MR, Carter DM, et al
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of
America on Group A Streptococcal (GAS) Pharyngitis: Risk assessment using
clinical scoring systems in children and adults.
Clin Infect Dis. 2025 Dec 4:ciaf668. doi: 10.1093.
Curr Microbiol
- WANG Z, Wang T, Qian K, Tang B, et al
Manganese as a Cofactor in the Immunity of Mycobacterium tuberculosis Infection.
Curr Microbiol. 2025;83:78.
- MEGAT ZAKARIA PN, Lean SS, Mohd Desa MN, Aklilu E, et al
Genomic Insights into Multidrug-resistant Mammaliicoccus sciuri Carrying Novel
Staphylococcal Cassette Chromosome mec (SCCmec) Elements and Plasmids from Farm
Ruminants on the East Coast of Peninsular Malaysia.
Curr Microbiol. 2025;83:72.
- WANG L, Wang Y, Yue H, Wang W, et al
Synergistic Antibacterial Effects of Ceftazidime/Avibactam and Auranofin
Combination against Carbapenem-Resistant Klebsiella pneumoniae: In Vitro and in
Vivo Evaluation.
Curr Microbiol. 2025;83:66.
- LI P, Wang Y, Xu X
Ceftazidime Combined with Bifico Improves Therapeutic Efficacy and Intestinal
Safety in a Mouse Model of Pseudomonas aeruginosa Pneumonia.
Curr Microbiol. 2025;83:71.
- SINGH I, Sharma J, Sharma D, Ratn A, et al
Bedaquiline Resistance: A Looming Global Threat in Tuberculosis Management.
Curr Microbiol. 2025;83:57.
- JAMAL U, Rahman ZU, Qadir M, Hamayun M, et al
Aspergillus Welwitschiae Regulates Response of Wheat at Multiple Levels To
Alleviate Induced Chromate Stress.
Curr Microbiol. 2025;83:60.
- SONG D, Qi F, Liu J, Xu T, et al
In Vitro Antibacterial Effects of Haskap Berry (Lonicera caerulea L.) Ethanol
Extract against Diarrheagenic Escherichia coli.
Curr Microbiol. 2025;83:63.
Diagn Microbiol Infect Dis
- BONGOMIN F, Sitenda D, Ssekamatte P, Jonani B, et al
Method comparison of QIAGEN QuantiFERON-TB gold plus ELISA and LIAISON(R)
QuantiFERON-TB gold plus for latent tuberculosis infection detection in pregnant
ugandan women.
Diagn Microbiol Infect Dis. 2025;114:117220.
- ELNAGAR RM, Elhosiny MM, Mamoun MA, Anber N, et al
Serological detection of invasive pulmonary aspergillosis in severely ill
COVID-19 patients.
Diagn Microbiol Infect Dis. 2025;114:117212.
- DU M, Zhou J, Zhang Z, Hao T, et al
Rapid diagnosis of tuberculosis using a three-dimensional nanofiber paper-based
electrochemical sensor.
Diagn Microbiol Infect Dis. 2025;114:117210.
- POLLANI C, Floch P, Grouteau G, Brousse A, et al
Real-life assessment of the VirClia(R) IgG chemiluminescence test for the diagnosis
of Bartonella henselae infection.
Diagn Microbiol Infect Dis. 2026;114:117187.
- AZIMIRAD M, Noori M, Looha MA, Anantharajah A, et al
Effect of sub-minimum inhibitory concentrations of metronidazole, vancomycin, and
fidaxomicin on growth rate and virulence of Clostridioides difficile.
Diagn Microbiol Infect Dis. 2026;114:117184.
- YU Z, Jiang Q, Qin J, Zhang Z, et al
Comparative evaluation of MALDI-TOF MS and PFGE for typing and transmission
analysis of Corynebacterium striatum in an ICU setting.
Diagn Microbiol Infect Dis. 2026;114:117178.
- MERTENS K, Thai KTD
Impact of collection and transport medium on the diagnostic performance of
bacterial vaginosis.
Diagn Microbiol Infect Dis. 2026;114:117182.
- MANOJ, Gupta Y, Ghrera AS
Paper modification strategies for bacterial sensing: Progress and prospects in
pathogen detection.
Diagn Microbiol Infect Dis. 2026;114:117180.
- HUANG S, Shi W, Chen L, Liu Y, et al
Sarocladium strictum meningoencephalitis with cerebral vasculitis: a case report
and literature review.
Diagn Microbiol Infect Dis. 2026;114:117171.
- CETINKAYA U, Sezer G, Al Khalif O, Koseoglu E, et al
Evaluation of the use of vinpocetine in microsporidia infections.
Diagn Microbiol Infect Dis. 2026;114:117170.
- JI H, Zhan S, Yang N, Hou X, et al
Clinical decision making impact of Next-Generation Sequencing in Pneumocystis
jirovecii infection: infection characteristics and prognosis.
Diagn Microbiol Infect Dis. 2026;114:117175.
- LIU M, Chen J, He W, Yu Q, et al
The first case of subcutaneous Fusariosis in an immunocompetent host in China: A
case report.
Diagn Microbiol Infect Dis. 2026;114:117173.
- GASIMOVA M, Gurbanov A, Kadyrova A, Huseynov R, et al
Diagnostic potential of non-invasive tests for Helicobacter pylori-associated
gastroduodenal disease in a resource-limited laboratory setting.
Diagn Microbiol Infect Dis. 2026;114:117167.
- SAMADI N, Hadi N, Hosainzadegan H, Kalani M, et al
Rapid detection of carbapenem resistance in Klebsiella pneumoniae clinical
isolates: Flow cytometry as an alternative to multiplex PCR.
Diagn Microbiol Infect Dis. 2026;114:117166.
- ESMAEILI F, Arjomandzadegan M, Zaboli F, Sarmadian H, et al
Frequency and antibiotic resistance profile of Clostridioides difficile among
cancer patients in an adult hematology-oncology unit: Contributing factors and
Follow up.
Diagn Microbiol Infect Dis. 2026;114:117147.
- MARSHALL KA, Chen DJ
Evaluation of organism inclusion on five rapid blood pathogen identification
systems and clinical significance of off-panel organisms.
Diagn Microbiol Infect Dis. 2026;114:117154.
- GHORBEL M, Kolsi F, Makni S, Cherif I, et al
Exploring complexity: A compelling case of chronic allergic fungal sinusitis
caused by Alterna Alternata with intracranial expansion and orbital involvement
in an immunocompetent male - An illuminating case study and in-depth literature
review.
Diagn Microbiol Infect Dis. 2026;114:117146.
- GUNAYDIN B, Kutlu HH, Kurc MA
Evaluation of the VITEK 2 second-generation cassette for colistin susceptibility
testing in carbapenem-resistant gram-negative bacteria.
Diagn Microbiol Infect Dis. 2026;114:117148.
- SANCHEZ D, de Michelena P, Camacho J, Belizon B, et al
Rapid detection of susceptibility to the ceftazidime-avibactam/aztreonam
combination and cefiderocol in MBL-producing Enterobacterales by MALDI-TOF MS and
turbidimetry.
Diagn Microbiol Infect Dis. 2026;114:117142.
- EBINI-AKO TA, Tanih NF, Djakissam W
Malaria and salmonella typhi co- infection and antibiotic susceptibility in
febrile patients at the Buea Regional Hospital.
Diagn Microbiol Infect Dis. 2026;114:117135.
- SCHLABE S, Asseva G, Brands-Jordan U, Hollerbach S, et al
Surprising uncovering of gram-negative diplococci from blood cultures: First
identification of Pseudoroseomonas aerofrigidensis as probable bloodstream
infection - clinical and laboratory approach towards an unknown pathogen.
Diagn Microbiol Infect Dis. 2026;114:117137.
- KUCHIBIRO T, Nakamura T, Niki M, Yamasaki K, et al
In vitro activity of essential antimicrobial agents, including
ceftazidime/avibactam, imipenem/relebactam, and cefiderocol, against
carbapenem-resistant Gram-negative bacteria primarily harboring the IMP-type
carbapenemase gene in the Kinki region of
Diagn Microbiol Infect Dis. 2026;114:117138.
- TRAN A, Amamoto A, Bates M, Leonard J, et al
Prevalence of Mycoplasma genitalium in a Southern California patient population.
Diagn Microbiol Infect Dis. 2026;114:117130.
- AHMAD J, Khan MA, Atif M, Rahman ZU, et al
Incidence and antimicrobial resistance profile of multi-drug resistant Salmonella
typhi isolated from blood samples in Khyber Pakhtunkhwa, Pakistan.
Diagn Microbiol Infect Dis. 2026;114:117122.
- JIANG B, Koo SH, Ang DSW, Ang TL, et al
Development of a real-time polymerase chain reaction (RT-PCR) assay for
simultaneous detection of Helicobacter pylori infection and genetic mutations
associated with clarithromycin resistance: A single-center, cross-sectional study
from Singapore.
Diagn Microbiol Infect Dis. 2026;114:117131.
- SOLTAU SR, Monrad NEP, Nielsen AEV, Ehlers-Hansen J, et al
Pseudomonas guariconensis Necrotizing soft tissue infection, Denmark.
Diagn Microbiol Infect Dis. 2026;114:117121.
- SARTORI L, Sellera FP, Furlan JPR, Moura Q, et al
Pet-human transmission of CTX-M-8 extended-spectrum beta-lactamase-producing
Escherichia coli ST961 and phylogenetic group B2.
Diagn Microbiol Infect Dis. 2026;114:117120.
- HARIDAS H, Raina S, Das P, Kunwar S, et al
Evaluation of colistin susceptibility among Klebsiella pneumoniae isolates by
broth microdilution and colistin agar test.
Diagn Microbiol Infect Dis. 2026;114:117119.
- JIANG F, Zhou X, Zhang H, Yuan H, et al
Analysis of Predictive Factors for Mycoplasma-associated Plastic Bronchitis in
Children.
Diagn Microbiol Infect Dis. 2026;114:117073.
- BAWANKAR NS, Sayed SEH, Bhise SM, Gaind R, et al
"Is the Ceftazidime-avibactam plus aztreonam combination a solution for
infections caused by metallo-beta-lactamase producing carbapenem-resistant
Enterobacterales? A call for further investigation".
Diagn Microbiol Infect Dis. 2026;114:117107.
- MASSARO C, Cala C, Anastasia A, Lupo S, et al
Anaerobic breast abscess caused by Prevotella bivia in non-lactating woman: A
case report with diagnostic and clinical implications.
Diagn Microbiol Infect Dis. 2026;114:117112.
Eur J Clin Microbiol Infect Dis
- ZERBATO V, Toc DA, Di Bella S, Lagatolla C, et al
Synergistic activity of fosfomycin combined with old and new oxazolidinones
(linezolid, contezolid, delpazolid, and sutezolid) against bloodstream isolates
of vancomycin-resistant Enterococcus faecium.
Eur J Clin Microbiol Infect Dis. 2025 Dec 12. doi: 10.1007/s10096-025-05372.
J Biol Chem
- SIROY A, Sun D, Paul A, Rowland JL, et al
Oligomerization is Required for Channel Formation of MctB and for Copper
Resistance of Mycobacterium tuberculosis.
J Biol Chem. 2025 Dec 9:111037. doi: 10.1016/j.jbc.2025.111037.
- ROSZKOWSKI EK, Charap S, Montague CR, Sukheja P, et al
Inhibition of de novo fatty acid synthesis in Mycobacterium tuberculosis.
J Biol Chem. 2025 Dec 8:111022. doi: 10.1016/j.jbc.2025.111022.
- SEKI K, Senoo A, Nagatoishi S, Yanaka S, et al
Structural basis for heme binding by the Shr protein from Streptococcus pyogenes.
J Biol Chem. 2025 Dec 5:111012. doi: 10.1016/j.jbc.2025.111012.
J Clin Microbiol
- FENG Z, Ge S, Miao P, Liu M, et al
Diagnostic performance of the Sanity 2.0 assay to detect resistance to
rifampicin, isoniazid, and fluoroquinolones in tuberculosis.
J Clin Microbiol. 2025 Dec 10:e0129925. doi: 10.1128/jcm.01299.
- OLABAMIJI JO, Ochei K, Daniel O, Eneogu R, et al
Evaluation of stool-based testing to diagnose tuberculosis in children using the
Truenat platform in routine settings in Nigeria.
J Clin Microbiol. 2025 Dec 10:e0104125. doi: 10.1128/jcm.01041.
- LI Y, Lin W, Li Z, Tran T, et al
Whole-genome sequencing-based pathogen characterization for streptococcal
infection directly from positive blood culture samples.
J Clin Microbiol. 2025 Dec 8:e0112625. doi: 10.1128/jcm.01126.
J Immunol
- BOTBOL Y, Alves V, Nimrichter L, Macian F, et al
Extracellular vesicles from Candidozyma (Candida) auris inhibit proliferation of
CD4 T cells by disrupting the IL-2 axis.
J Immunol. 2025 Dec 6:vkaf302. doi: 10.1093.
J Infect Dis
- ERNST JD
Clinical Commentary on: Targeting Tryptophan Metabolism for Tuberculosis
Biomarkers and Host Directed Therapy.
J Infect Dis. 2025 Dec 11:jiaf624. doi: 10.1093.
J Med Chem
- YE J, Kan CH, Liu J, Tsang TF, et al
Dithioether Inhibitors of Bacterial RNA Polymerase-Sigma Factor Interactions
Exhibit In Vivo Efficacy against MRSA.
J Med Chem. 2025;68:25352-25374.
J Med Microbiol
- NAKANO S, Fujisawa T, Koide S, Sugawara Y, et al
Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae in
paediatric patients in Japan (2020-2023).
J Med Microbiol. 2025;74:002105.
- YIN S, Li L, Zhu L, He J, et al
The synergistic pathogenic mechanism of Brucella melitensis M5-90 effector
protein BspC in regulating host cell apoptosis, inflammation and oxidative
stress.
J Med Microbiol. 2025;74:002092.
- WU Z, Li X, Dou X, Yang H, et al
Targeted detection of Helicobacter pylori resistance to clarithromycin and
levofloxacin using single-cell Raman spectroscopy.
J Med Microbiol. 2025;74:002094.
JAMA
- BURSTEIN B, Waterfield T, Umana E, Xie J, et al
Prediction of Bacteremia and Bacterial Meningitis Among Febrile Infants Aged 28
Days or Younger.
JAMA. 2025 Dec 8:e2521454. doi: 10.1001/jama.2025.21454.
Lancet
- LATEEF S
Aid cuts hampering Nepal's tuberculosis care.
Lancet. 2025 Dec 4:S0140-6736(25)02469-9. doi: 10.1016/S0140-6736(25)02469.
MMWR Morb Mortal Wkly Rep
- LIM S, Vagnone PS, Marshall NC, Lees C, et al
Detection of Paraburkholderia in Clinical Specimens Associated with Use of
Nonsterile Ultrasound Gel for Percutaneous Procedures - United States, Canada,
and Israel, May 2023?April 2025.
MMWR Morb Mortal Wkly Rep. 2025;74:615-621.
PLoS Biol
- VEZINA B, Cooper HB, Barlow CK, Rethoret-Pasty M, et al
A metabolic atlas of the Klebsiella pneumoniae species complex reveals
lineage-specific metabolism and capacity for intra-species co-operation.
PLoS Biol. 2025;23:e3003559.
PLoS Med
- GOTTLIEB SL, Rees H, Peters RPH
Vaccines to prevent bacterial sexually transmitted infections: Promise, progress,
and public health potential.
PLoS Med. 2025;22:e1004849.
PLoS Negl Trop Dis
- SHRESTHA D, Shrestha B, Ansari S, Sharma S, et al
Fostering empowerment: Transition from self-help groups to cooperatives in
leprosy-affected communities in Nepal.
PLoS Negl Trop Dis. 2025;19:e0013799.
- GASSIEP I, Chewapreecha C, Chantratita N, Oakley T, et al
Laboratory diagnosis of melioidosis.
PLoS Negl Trop Dis. 2025;19:e0013761.
- ZHAN T, Li Y, Xie Y, Li S, et al
Multiepitope fusion protein-based ELISA for enhanced brucellosis serodiagnosis.
PLoS Negl Trop Dis. 2025;19:e0013804.
- PROHASKA-BATISTA F, Bridi Cavassin F, de Queiroz-Telles F
From neglected to notable: A growing public health challenge driven by
hospitalization for sporotrichosis in Pernambuco, Northeast Brazil (2016-2024).
PLoS Negl Trop Dis. 2025;19:e0013795.
- KARANI V, Dierro L, Rono A, Githiomi M, et al
Associated Factors of Mycobacterium Leprae Infection among People with Leprosy in
Kwale County.
PLoS Negl Trop Dis. 2025;19:e0012901.
PLoS One
- STANDL F, Senger L, Stich H
Prevalence of sexually transmitted infections and immunization status among
registered sex workers: A pilot study in lower Bavaria, Germany.
PLoS One. 2025;20:e0338710.
- URIBE-RIVERA J, Nava-Ramirez MJ, Escobedo-Aguirre S, Del Rio-Garcia JC, et al
Generation of a primary culture of chick embryo enterocytes to evaluate the
effects of fumonisin B1 and deoxynivalenol on cell morphology, actin filaments
and nuclei.
PLoS One. 2025;20:e0334395.
- OCTOBER CD, Baloyi DP, Viljoen L, Raad R, et al
Using participatory methods to develop a narrative intervention to alleviate
distress in children hospitalised with TB in South Africa: The DIMPle project.
PLoS One. 2025;20:e0338394.
- WANG J, Chang T, Wang Y, Zhang J, et al
Association between Anti-Helicobacter pylori IgG seropositivity on coronary heart
disease and potential pathogenesis: a Mendelian randomization study.
PLoS One. 2025;20:e0329137.
- ASMAMAW B, Tadese TT, Mamo RY, Taye BA, et al
Magnitude of tuberculosis treatment outcomes and associated factors in public
health institutions of Arba Minch town, Southern Ethiopia: A multi-centered
retrospective cross-sectional study.
PLoS One. 2025;20:e0338393.
- GETAHUN M, Kebede Y, Molalegn H, Alemu A, et al
Contribution of xpert MTB/RIF assay and Urine LF-LAM for the diagnosis of
tuberculosis in children aged 5 - 14 years, at selected health facilities in
Ethiopia, 2016 - 2019.
PLoS One. 2025;20:e0338557.
- FOWORA M, Adewale B, Mogaji H, Omolopo I, et al
Co-infections of Schistosoma mansoni and Helicobacter pylori in school-aged
populations and implication for management and control practices in Niger State,
Nigeria.
PLoS One. 2025;20:e0337423.
- TEMBO D, Musonda NC, Simwaka M, Nkwemu C, et al
Rapid progression and short-term mortality during the January 2023 to July 2024
Cholera outbreaks in Zambia: A retrospective facility-based study.
PLoS One. 2025;20:e0330969.
- HERNANDEZ VM, Gama-Martinez Y, Segovia L, Hernandez-Lucas I, et al
Functional role of 18 LysR-Type transcriptional regulators of Salmonella enterica
serovar Typhi.
PLoS One. 2025;20:e0338130.
- MARKUS I, Meurs L, Wood R, Razafimbia V, et al
Knowledge, attitude and practices among Healthcare Workers towards Pulmonary
Plague Infection following an outbreak in Madagascar, 2017: A pilot study.
PLoS One. 2025;20:e0336589.
- GETIE M, Tafere W, Tsega A, Gebreyesus T, et al
Antimicrobial resistance profiles of bacteria from clinical specimens at Amhara
Public Health Institute, Bahir Dar, Ethiopia: A retrospective study.
PLoS One. 2025;20:e0337332.
- VACCA P, Vescio F, D'Ancona F, Fazio C, et al
Neisseria meningitidis serogroup B causing invasive disease, Italy, 2010-2021.
PLoS One. 2025;20:e0337446.
- MOHAMMED FA, Sarkar R, Ayele F, Urgesa K, et al
Nasopharyngeal carriage of Streptococcus pneumoniae, its associated factors, and
antimicrobial susceptibility patterns among school children in Babile district,
eastern Ethiopia.
PLoS One. 2025;20:e0337950.
- KATEETE DP, Namakula S, Kigozi E, Katabazi FA, et al
Patterns of compensatory mutations in rpoA/B/C genes of multidrug resistant M.
tuberculosis in Uganda.
PLoS One. 2025;20:e0328957.
- HUSSEIN AM, Muhialdin AJ, Faraj RK
Prevalence of antibiotic-resistant Escherichia coli isolates from healthy chicken
droppings.
PLoS One. 2025;20:e0337055.
- TIWA BN, Fankam AG, Sonfack CB, Mouozong R, et al
Correction: Anti-staphylococcal activity, antibiotic-resistance modulation
effects and action of Harungana madagascariensis (Hypericaceae) fruit extracts on
the antioxidant system of multidrug-resistant Staphylococcus aureus.
PLoS One. 2025;20:e0338020.
PLoS Pathog
- ENZ U, Gul E, Maurer L, Cerepenkaite K, et al
TTSS-2 virulence drives inflammatory destruction of the gut epithelial barrier
and modulates inflammatory response profiles in the Salmonella-infected mouse
gut.
PLoS Pathog. 2025;21:e1013733.
- SILVA M, Pinto AJ, Beites T
Essential redundancies fuel Mycobacterium tuberculosis adaptation to the host.
PLoS Pathog. 2025;21:e1013749.
- MEHRA A, Garrett EM, Serody CJ, Tamayo R, et al
Phase variation of Clostridioides difficile colony morphology occurs via
modulation of cell division.
PLoS Pathog. 2025;21:e1013471.
- BOTHRA A, Pomerantsev A, Schwarz B, Mondal A, et al
Environmental regulation of toxin production in Bacillus anthracis.
PLoS Pathog. 2025;21:e1013587.
- POSPISILOVA M, Dreus A, Matheova P, Schmidtova J, et al
Bimodal expression of Type 3 Secretion System 2 enables cooperative virulence
among intracellular Salmonella Typhimurium.
PLoS Pathog. 2025;21:e1013728.
- MULLER NF, Wick RR, Judd LM, Williamson DA, et al
Quantifying plasmid movement in drug-resistant Shigella species using
phylodynamic inference.
PLoS Pathog. 2025;21:e1013621.
- BECKMAN I V RL, Martinez B, Santiago FZ, Echeverria GN, et al
Molecular response to the non-lytic peptide bac7 (1-35) triggers disruption of
Klebsiella pneumoniae biofilm.
PLoS Pathog. 2025;21:e1013437.
- ROYER ALM, Dion E, Umansky AA, Avino M, et al
Structural determinants of SlpA-mediated phage recognition in Clostridioides
difficile.
PLoS Pathog. 2025;21:e1013724.
Proc Natl Acad Sci U S A
- BANERJEE A, Pickelner S, Smith F, Tenuta LMA, et al
Fluoride triggers lysis in Streptococcus mutans by inhibition of the Clp protease
complex, leading to an unabated competence cascade.
Proc Natl Acad Sci U S A. 2025;122:e2511884122.
- JANET-MAITRE M, Di Venanzio G, Jackson-Litteken CD, Scott NE, et al
Intracellular Acinetobacter baumannii acts as a transient reservoir in lung
infection via a "persist and resist" strategy.
Proc Natl Acad Sci U S A. 2025;122:e2511369122.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016